Merck & Co., Inc.
0
0
0%

Financials

Income statement

Fundamentals currency is USD
Fiscal date 2024 2023 2022 2021
Total reported revenue 54.7B 60.1B 59.3B 48.7B
Cost of revenue 12.9B 16.1B 17.4B 13.6B
Gross profit 41.7B 44.0B 41.9B 35.1B
Operating expense
Research & development 15.3B 30.5B 13.5B 12.2B
Selling general and admin 9.2B 10.5B 10.0B 9.6B
Other operating expenses
Operating income 17.2B 3.0B 18.3B 13.2B
Non operating interest income
Income 353.7M 365M 157M 36M
Expense 1.1B 1.1B 962M 806M
Other income expense 486.6M -284M -1.0B 1.5B
Pretax income 17.0B 1.9B 16.4B 13.9B
Tax provision 2.4B 1.5B 1.9B 1.5B
Net income 14.6B 377M 14.5B 12.4B
Basic EPS 6.8 0.1 5.7 5.2
Diluted EPS 6.7 0.1 5.7 5.1
Basic average shares 2.2B 2.7B 2.6B 2.6B
Diluted average shares 2.2B 2.7B 2.6B 2.6B
EBITDA 22.4B 7.5B 23.3B 16.9B
Net income from continuing op. 14.6B 377M 14.5B 12.4B
Minority interests -16M -12M -7M 691M
Preferred stock dividends
Access the full /income_statement historical dataset via the API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 7 hours 28 minutes

00:31
00:00
08:55
17:35
23:59

Trading Hours (Monday - Friday):

Pre-market
08:00 - 08:55
Main market
08:55 - 17:35
Post-market
17:35 - 17:50
All times are displayed in the Europe/Vienna timezone (CET, UTC+01:00).